BACKGROUND AND AIMS: Asymmetrical dimethylarginine (ADMA) may contribute to hypertension and cardiovascular disease by decreasing NO formation. In diabetic patients, a high fat meal acutely increased plasma ADMA while impairing endothelial function. We hypothesized that chronic and acute increases in dietary fat intake augment ADMA also in lean and in obese subjects without diabetes. METHODS AND RESULTS: Seventeen lean and twelve obese volunteers were randomized to two weeks of isocaloric diets with approximately 20% or >40% calories from fat in a cross-over fashion. At the end of the high and low fat periods, volunteers received corresponding test meals. ADMA was measured by GC-MS/MS using a deuterated standard. Mean fasting plasma ADMA co...
BACKGROUND: Whether the type of dietary fat could alter cardiometabolic responses to a hypercaloric ...
Copyright © 2014 Mustafa Celik et al. This is an open access article distributed under the Creative ...
Background. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase. ...
In recent years, the link between obesity, inflammation and atherosclerosis has attracted increasing...
In recent years, the link between obesity, inflammation and atherosclerosis has attracted increasing...
Impaired vascular endothelial function has been suggested as a possible mechanism to explain the nex...
BACKGROUND: Ghrelin has many biological activities such as regulating energy homeostasis and recent ...
Circulating asymmetrical dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthesis,...
he metabolic syndrome (MS) is a cluster of pathophysiological alterations that includes the presence...
Objective: We investigated the association of serum asymmetric dimethylarginine (ADMA) with metaboli...
Background and aim Impaired vasodilatation has been suggested to be caused by inhibi...
Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxideproduction and involved...
BACKGROUND: Asymmetric dimethylarginine (ADMA) plasma levels have been shown to be elevated in disea...
Abstract: Circulating asymmetrical dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide ...
BACKGROUND: Whether the type of dietary fat could alter cardiometabolic responses to a hypercaloric ...
BACKGROUND: Whether the type of dietary fat could alter cardiometabolic responses to a hypercaloric ...
Copyright © 2014 Mustafa Celik et al. This is an open access article distributed under the Creative ...
Background. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase. ...
In recent years, the link between obesity, inflammation and atherosclerosis has attracted increasing...
In recent years, the link between obesity, inflammation and atherosclerosis has attracted increasing...
Impaired vascular endothelial function has been suggested as a possible mechanism to explain the nex...
BACKGROUND: Ghrelin has many biological activities such as regulating energy homeostasis and recent ...
Circulating asymmetrical dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthesis,...
he metabolic syndrome (MS) is a cluster of pathophysiological alterations that includes the presence...
Objective: We investigated the association of serum asymmetric dimethylarginine (ADMA) with metaboli...
Background and aim Impaired vasodilatation has been suggested to be caused by inhibi...
Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxideproduction and involved...
BACKGROUND: Asymmetric dimethylarginine (ADMA) plasma levels have been shown to be elevated in disea...
Abstract: Circulating asymmetrical dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide ...
BACKGROUND: Whether the type of dietary fat could alter cardiometabolic responses to a hypercaloric ...
BACKGROUND: Whether the type of dietary fat could alter cardiometabolic responses to a hypercaloric ...
Copyright © 2014 Mustafa Celik et al. This is an open access article distributed under the Creative ...
Background. Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase. ...